iRhythm Technologies, maker of ZIO, a non-invasive wearable sensor patch for monitoring cardiac arrhythmia, closed a $17M Series E funding round led by Novo A/S. Norwest Venture Partners also participated in the oversubscribed round.
Salutron, a remote health monitoring device company, debuted its new LifeTrak app for both Android and iOs platforms. The LifeTrak syncs with LifeTrak Zone C410 or LifeTrak Move C300 device to give a comprehensive view of activity, sleep patterns and other health and fitness vitals.
endpoint Clinical, a provider of Interactive Response Technology systems for global clinical trials, launched its next-generation PULSE 3.0 platform. It provides highly customized configuration and deployment of complex trial designs in a rapid and repeatable manner.
Health Catalyst, a provider of health care data warehousing and analytics, was selected as one of the Red Herring Top 100 North America award winners for 2014. Health Catalyst’s Late-Binding Data Warehouse and Analytics platform allows health care organizations to view clinical and performance data from their EHR, financial, and patient satisfaction applications in a unified way.
Cigna and Samsung Electronics launched a smart health coaching service called Coach by Cigna as a part of S Health* on Samsung Galaxy S 5. Users can collect and integrate health information from their smartphones and new Samsung Gear devices, and use content, experience and engines provided by Cigna for valuable health insights.
Mango Health, a startup using gamification principals to work on medication adherence, raised $5.25 million in first round funding from Kleiner Perkins Caufield & Byers. The company, which participated in the Rock Health digital health accelerator in 2012, previously raised $3 million in a seed round.
Rock Health introduced its sixth class of startups that includes companies working on ICU analytics tools, primary care telehealth, population health, and a private health insurance exchange.
A randomized control trial of 99 elderly, Spanish patients indicated that a tablet app can improve medication adherence, even in patients with no prior experience with the internet, smartphones, or tablets.
Apixio raised a $13.5 million Series C round led by Bain Capital Ventures. Apixio applies big data technology to provide health plans and large provider groups with more accurate risk scores and reimbursement values. Apixio has raised over $20 million to date.